The impact of stepwise withdrawal of inhaled corticosteroids on exacerbations in COPD patients receiving dual bronchodilation: WISDOM study
H. Magnussen, P. Chanez, R. Dahl, M. Decramer, B. Disse, H. Finnigan, A. Kirsten, R. Rodriguez-Roisin, K. Tetzlaff, L. Towse, H. Watz, E. Wouters, P. Calverley (Grosshansdorf, Ingelheim, Tübingen, Germany; Marseille, France; Odense, Denmark; Leuven, Belgium; Berkshire, Liverpool, United Kingdom; Barcelona, Spain; Maastricht, Netherlands)
Source: International Congress 2014 – Bronchodilators for asthma and COPD
Session: Bronchodilators for asthma and COPD
Session type: Oral Presentation
Number: 1890
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Magnussen, P. Chanez, R. Dahl, M. Decramer, B. Disse, H. Finnigan, A. Kirsten, R. Rodriguez-Roisin, K. Tetzlaff, L. Towse, H. Watz, E. Wouters, P. Calverley (Grosshansdorf, Ingelheim, Tübingen, Germany; Marseille, France; Odense, Denmark; Leuven, Belgium; Berkshire, Liverpool, United Kingdom; Barcelona, Spain; Maastricht, Netherlands). The impact of stepwise withdrawal of inhaled corticosteroids on exacerbations in COPD patients receiving dual bronchodilation: WISDOM study. Eur Respir J 2014; 44: Suppl. 58, 1890
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: